SG161201A1 - Production process for nsaid-containing lozenges, their compositions, their medicinal use - Google Patents

Production process for nsaid-containing lozenges, their compositions, their medicinal use

Info

Publication number
SG161201A1
SG161201A1 SG201001311-8A SG2010013118A SG161201A1 SG 161201 A1 SG161201 A1 SG 161201A1 SG 2010013118 A SG2010013118 A SG 2010013118A SG 161201 A1 SG161201 A1 SG 161201A1
Authority
SG
Singapore
Prior art keywords
nsaid
lozenge
compositions
salt
production process
Prior art date
Application number
SG201001311-8A
Other languages
English (en)
Inventor
Michael Fanfarillo
Paul Marshall
Kirsty Jozefa Sawicka
Jasmine Takhar
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG161201(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of SG161201A1 publication Critical patent/SG161201A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG201001311-8A 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use SG161201A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0504157A GB2423710A (en) 2005-03-01 2005-03-01 Lozenge production process

Publications (1)

Publication Number Publication Date
SG161201A1 true SG161201A1 (en) 2010-05-27

Family

ID=34430399

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201001311-8A SG161201A1 (en) 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use

Country Status (21)

Country Link
US (2) US10328039B2 (zh)
EP (3) EP2210587A1 (zh)
JP (1) JP2008531664A (zh)
KR (2) KR101358687B1 (zh)
CN (2) CN101132762A (zh)
AU (1) AU2006219777B2 (zh)
CA (1) CA2599861A1 (zh)
DK (1) DK1853220T3 (zh)
ES (2) ES2886323T3 (zh)
GB (1) GB2423710A (zh)
HU (1) HUE034872T2 (zh)
MX (1) MX2007009275A (zh)
MY (1) MY154770A (zh)
PL (2) PL1853220T5 (zh)
PT (1) PT1853220T (zh)
RU (1) RU2403032C2 (zh)
SG (1) SG161201A1 (zh)
SI (2) SI1853220T2 (zh)
TW (1) TWI372065B (zh)
WO (1) WO2006092569A1 (zh)
ZA (1) ZA200706067B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090104236A1 (en) * 2007-10-18 2009-04-23 Pharmaceutics International, Inc. Pharmaceutical solid hybrids
GB201215988D0 (en) * 2012-09-07 2012-10-24 Reckitt Benckiser Healthcare Int Ltd Pharmaceutical compositions comprising flurbiprofen
US9914968B2 (en) 2012-09-26 2018-03-13 Cepheid Honeycomb tube
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
EP4017488A4 (en) * 2019-08-22 2024-01-10 Applied Biological Laboratories, Inc. COMPOSITIONS AND METHODS USING NON-STEROID ANTI-INFLAMMATORY DRUGS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084864A (en) 1964-02-06 1967-09-27 Merck & Co Inc Medicated lozenges
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU8107998A (en) 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
ATE329583T1 (de) 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
US6689382B2 (en) 2002-05-15 2004-02-10 Procaps S.A. Soft shell gelatin capsules containing non-steroidal anti-inflammatories
US20070190153A1 (en) 2004-03-05 2007-08-16 Jonathan Farber Delivery systems for non-steroidal anti-inflammatory drugs (nsaids)

Also Published As

Publication number Publication date
AU2006219777B2 (en) 2010-07-01
PT1853220T (pt) 2017-11-17
CN101132762A (zh) 2008-02-27
DK1853220T3 (da) 2017-11-13
EP3284458B1 (en) 2021-06-16
US20190307711A1 (en) 2019-10-10
US20080206326A1 (en) 2008-08-28
MX2007009275A (es) 2007-09-19
KR20140011422A (ko) 2014-01-28
HUE034872T2 (hu) 2018-03-28
ES2647488T3 (es) 2017-12-21
SI1853220T1 (sl) 2017-12-29
MY154770A (en) 2015-07-15
ZA200706067B (en) 2008-09-25
CN103156818A (zh) 2013-06-19
JP2008531664A (ja) 2008-08-14
PL1853220T3 (pl) 2018-01-31
US10328039B2 (en) 2019-06-25
AU2006219777A1 (en) 2006-09-08
ES2886323T3 (es) 2021-12-17
EP2210587A1 (en) 2010-07-28
US10933040B2 (en) 2021-03-02
EP3284458A1 (en) 2018-02-21
WO2006092569A1 (en) 2006-09-08
PL3284458T3 (pl) 2021-12-13
EP1853220B1 (en) 2017-08-16
SI3284458T1 (sl) 2021-11-30
EP1853220A1 (en) 2007-11-14
SI1853220T2 (sl) 2023-07-31
GB2423710A (en) 2006-09-06
CA2599861A1 (en) 2006-09-08
EP1853220B2 (en) 2023-03-29
KR101358687B1 (ko) 2014-02-07
PL1853220T5 (pl) 2023-08-07
GB0504157D0 (en) 2005-04-06
ES2647488T4 (es) 2024-01-16
ES2647488T5 (es) 2023-08-09
RU2007136106A (ru) 2009-04-10
TW200716199A (en) 2007-05-01
TWI372065B (en) 2012-09-11
KR20070110053A (ko) 2007-11-15
RU2403032C2 (ru) 2010-11-10

Similar Documents

Publication Publication Date Title
SG149080A1 (en) Composition comprising a nsaid and paracetamol
GT200500384A (es) Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada
CL2010001275A1 (es) Metodo para producir un producto intermedio compactado de bibw 2992 ma2 que comprende una etapa de compactacion por rodillos de bibw 2992 ma2 u opcionalmente en una premezcla con 0-1,0% de lubricante en un mezclador de caida libre o de volteo y una etapa de tamizado; producto intermedio compactado; comprimido.
AR028988A1 (es) Derivados amida, proceso para su preparacion, composicion farmaceutica que los comprende, y su uso en la fabricacion de un medicamento util en el tratamiento de enfermedades o afecciones clinicas mediadas por citoquinas
BRPI0510034A (pt) forma de dosagem para distribuição de múltiplas formas de fármacos
NZ592276A (en) PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(epsilon-CAPROLACTONE) AND AN OPIOID
EA017764B8 (ru) Фармацевтическая композиция, способ ее получения и способ лечения вирусных заболеваний с ее использованием
RU2010148536A (ru) Способ непрерывного изготовления фармацевтических композиций
SI1746980T1 (sl) Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo
SG161201A1 (en) Production process for nsaid-containing lozenges, their compositions, their medicinal use
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
DE602004020494D1 (de) Analgetische verbindungen, deren synthese und pharmazeutische zusammensetzungen, die diese enthalten
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
HRP20040944B1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
BRPI0518789A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
BRPI0518786A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
MXPA05013392A (es) Composiciones farmaceuticas de atorvastatina.
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
WO2018005794A3 (en) Novel non-systemic tgr5 agonists
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
BRPI0605893A (pt) composição farmacêutica, cápsula única, forma unitária de dosagem oral única, processos de produção de uma composição farmacêutica, dos ingredientes ativos cristalinos e recristalizado do ácido suberoilanilida hidroxámico, e de obtenção do ácido suberoilanilida hidroxámico cristalino, e, composição cristalina
SA522441056B1 (ar) مُركّب جديد من كبريتات [2-(داي ميثيل أمينو)-2-فينيل بيوتيل]-3، 4، 5-تراي ميثوكسي بنزوات 4-ميثيل-2h-كرومين-2-ون-7-يل واستخدامه